SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-009221
Filing Date
2023-03-22
Accepted
2023-03-22 16:52:16
Documents
14
Period of Report
2023-03-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cycn-20230322.htm   iXBRL 8-K 66627
2 EX-99.1 cycn-ex99_1.htm EX-99 23346
3 GRAPHIC img121346916_0.jpg GRAPHIC 15783
  Complete submission text file 0000950170-23-009221.txt   245032

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cycn-20230322_lab.xml EX-101.LAB 18519
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cycn-20230322.xsd EX-101.SCH 2477
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cycn-20230322_pre.xml EX-101.PRE 11562
8 EXTRACTED XBRL INSTANCE DOCUMENT cycn-20230322_htm.xml XML 4876
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 23753526
SIC: 2834 Pharmaceutical Preparations